洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR2000031098】Muscle ultrasonography and frailty in cardiac surgery

基本信息
登记号

ChiCTR2000031098

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2020-03-22

临床申请受理号

/

靶点

/

适应症

Cardiovascular disease

试验通俗题目

Muscle ultrasonography and frailty in cardiac surgery

试验专业题目

Correlation between muscle ultrasonographic assessment of rectus femoris and Clinical Frailty Scale in elective cardiac surgical patients

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

The secondary objectives of this study are to: 1. Determine the association between preoperative muscle ultrasonographic assessment on MT, CSA and echogenicity of RF, and physical performance and activity level. 2. Determine the association between preoperative muscle ultrasonographic assessment on MT, CSA and echogenicity of RF, and postoperative outcomes up to 30 days after surgery.

试验分类
试验类型

队列研究

试验分期

诊断试验新技术

随机化

N/A

盲法

N/A

试验项目经费来源

Internal funding of the department

试验范围

/

目标入组人数

85

实际入组人数

/

第一例入组时间

2020-04-01

试验终止时间

2021-05-31

是否属于一致性

/

入选标准

All adult patients scheduled for elective cardiac surgery admitted to the cardiothoracic surgical ward a day before surgery will be asked to participate in the cohort study. They will be enrolled if written informed consent is made. We will recruit 85 consecutive patients undergoing major elective cardiac surgery, including coronary artery bypass graft, valve surgery or aortic intervention.;

排除标准

We will exclude patients undergoing emergency cardiac surgery, or patients with known musculoskeletal or neurological disorders that are associated with lower limb muscle atrophy (e.g. poliomyelitis, stroke, peripheral neuropathy); previous major surgery at lower extremity (e.g. hip replacement, metal implants at femur); or conditions that influence or are unsuitable for muscle ultrasonographic assessment, such as localised infection, skin disorders or compromised skin integrity, severe edema over thigh, and cognitive impairment (inability to provide consent).;

研究者信息
研究负责人姓名
试验机构

N/A

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

N/A的其他临床试验

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品